organophosphonates has been researched along with Castleman Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldstein, D; Kelly, J; Lloyd, A; Rawlinson, W; Senanayake, S; Waliuzzaman, Z | 1 |
| Agbalika, F; Berezne, A; Oksenhendler, E | 1 |
2 other study(ies) available for organophosphonates and Castleman Disease
| Article | Year |
|---|---|
Multicentric Castleman's disease treated with antivirals and immunosuppressants.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Antiviral Agents; Castleman Disease; Chlorambucil; Cidofovir; Cytosine; Drug Therapy, Combination; Foscarnet; Herpesvirus 8, Human; Humans; Immunosuppressive Agents; Male; Organophosphonates; Organophosphorus Compounds; Prednisolone; Sarcoma, Kaposi; Treatment Outcome | 2003 |
Failure of cidofovir in HIV-associated multicentric Castleman disease.
Topics: Anti-HIV Agents; Castleman Disease; Cidofovir; Cytosine; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Treatment Failure | 2004 |